Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6921118 | 0.87 | PLAU (1.00) | PLAUC1S | |
| Hydrochloric Acid SCHEMBL6920517 | 0.86 | PLAU (0.98) | PLAUC1S | |
| SCHEMBL6927765 | 0.86 | PLAU (0.81) | PLAUC1S | |
| SCHEMBL6926957 | 0.81 | PLAU (1.00) | PLAU | |
| Hydrochloric Acid SCHEMBL6924685 | 0.81 | PLAU (0.98) | PLAU | |
| SCHEMBL6924572 | 0.80 | PLAU (0.85) | PLAU | |
| SCHEMBL6921325 | 0.79 | PLAU (1.00) | PLAU | |
| SCHEMBL6927014 | 0.79 | PLAU (1.00) | PLAU | |
| Hydrochloric Acid SCHEMBL6920895 | 0.79 | PLAU (0.84) | PLAU | |
| SCHEMBL6921738 | 0.79 | PLAU (1.00) | PLAU |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020037915-A1 | Compounds and compositons for treating C1s-mediated diseases and conditions | 3-DIMENSIONAL PHARMACEUTICALS, INC. | 2002-03-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020037915-A1 | Compounds and compositons for treating C1s-mediated diseases and conditions | C1S, C1R, C9 | PLAU 229/4885C1S 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.